The ASX 200 (ASX: XJO) is currently up more than 2% as investors react to the vaccine news.
What has happened with a vaccine?
According to reporting by international media, US business Moderna has announced that a vaccine may be able to help people’s immune system fight COVID-19.
Apparently antibodies were found in the first eight people who took part in the safety trials. The people’s immunity response was similar to people with the actual coronavirus.
The vaccine trial was run by the US government’s National Institute of Allergy and Infectious Diseases. A large trial is expected to take place in July.
Baby Bunting (ASX: BBN) share price soars
The Baby Bunting share price is currently up 13.5% after the baby product retailer gave a business update.
The retailer announced its trading performance for the second half from 30 December 2019 to 17 May 2020.
Total sales growth has been 13.2% with comparable store sales growth of 8.1%. Online sales are 17.3% of total sales, representing growth of around 66% compared to the prior corresponding period.
Baby Bunting also released its numbers on a financial year to date (YTD) basis. Total sales growth is 10.3%, comparable store sales growth is 3.4% and online sales have been 14.3% of total sales which represents growth of around 34%.
James Hardie Industries (ASX: JHX) share price jumps
The James Hardie Industries share price is up almost 10% after releasing its preliminary full year result.
The building materials business said that net sales were up 4% to US$2.6 billion. Net profit was up 6% to US$241.5 million.
As a reminder, the company announced the suspension of dividends until further notice on 5 May 2020.
[ls_content_block id=”695″ para=”paragraphs”]
Disclosure: Jaz does not own shares of any of the shares mentioned at the time of writing.